Company Filing History:
Years Active: 2009
Title: Robb B Nicewonger: Innovator in Cancer Treatment
Introduction
Robb B Nicewonger is a notable inventor based in Tyngsboro, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the inhibition of RAF kinase, which plays a crucial role in cell proliferation.
Latest Patents
Robb B Nicewonger holds a patent for RAF inhibitors and their uses. The patent describes imidazooxazole and imidazothiazole compounds and their synthesis. These compounds are capable of inhibiting the activity of RAF kinase, particularly B-RAF. The invention is particularly useful for treating cell proliferative disorders such as cancer. He has 1 patent to his name.
Career Highlights
Robb B Nicewonger is associated with Arqule, Inc., a company dedicated to developing targeted therapies for cancer. His work at Arqule has positioned him as a key player in the pharmaceutical industry, contributing to advancements in cancer treatment.
Collaborations
Throughout his career, Robb has collaborated with talented individuals such as Jean-Marc Lapierre and Nivedita Namdev. These collaborations have further enhanced his research and development efforts in the field of oncology.
Conclusion
Robb B Nicewonger is a dedicated inventor whose work in developing RAF inhibitors has the potential to significantly impact cancer treatment. His contributions to the field exemplify the importance of innovation in addressing critical health challenges.